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A number of cross-sectional, static-group studies
have suggested that douching can be linked to
bacterial vaginosis (BV) in pregnant women, non-
pregnant women attending sexually transmitted
disease (STD) clinics, and non-pregnant female
sex workers in Nairobi1–4. Gresenguet and co-
workers5 advanced data which they interpreted
as linking human immunodeficiency virus
acquisitiontodouching.Otherstudieshaveciteda
linkage between douching and pelvic inflamma-
tory disease, preterm labor, preterm delivery and
cervical cancer6–9.
The vast amount of federal funding to support,
in particular, the Seattle groups10–16 has attested
to the perceived importance of this issue for
women’s healthcare. Douching is a common
practice for which there is little scientific data to
support or repudiate the stated allegations. Never-
theless, serious discussions have been held by
the Food and Drug Administration as to the
banning of commercial douching preparations. If




designs chosen. The studies suggesting a causal
relationshiphavebeenprimarilystatic-groupcom-
parisons and/or pseudo- or quasi-experimental
designs17,18. While these designs can effectively
pose the hypothesis, they do not constitute a
validating scientific vehicle.
To look critically at the control of potentially
invalidating variables for douching, one needs
to begin with those which impact on BV
study populations. Identical claims of causality
(pelvic inflammatory disease, ectopic pregnancy,
secondary infertility, preterm births) have been
advanced for BV as have been claimed for
douching.Rosenbergandco-workers9hadidenti-
fied three characteristics that stood out among
women who douched: lower socioeconomic
status, greater risk of sexually transmitted diseases
and symptoms suggestive of vaginal infections.
Multiple studies of women with BV have revealed
a high incidence of co-infections with other
STD pathogens and, in particular, Chlamydia
trachomatis10,11,19–23. No mechanism has been
demonstrated how douching causes pelvic inflam-
matory disease, ectopic pregnancies, secondary
infertility; however, such data does exist for
Chlamydia trachomatis, in the absence of
douching.
Recently, Ness and co-workers reported on a
multi-institutional National Institutes of Health
(NIH)-fundedprojectwhichstudied1200women
at high risk for STDs in order to document a
possible association between douching and BV24.




that, rather than douching causing the long-term
sequelae to women, douching causes BV which in
turn causes the stated outcomes. The investigators
proposed that douching predisposes to BV by
disrupting the normal vaginal flora.
They identified, as other studies have docu-
mented, that women of black race, low education,
low income and a history of STDs were more
likely to have BV than normal flora (76.5%
versus 19.1%). Women who were never pregnant,
smoked and had sexual intercourse with menses
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 2003 The Parthenon Publishing Group 135were also more likely to have BV. Douching once
a month or more elevated the risk of having BV or
what they termed ‘intermediate vaginal flora’
(IVF) by a factor of 1.4. Those women who found
it necessary to douche within the past 7 days were
at even higher risk of having BV or IVF. Women
with BV or IVF had a higher prevalence of
gonococcal or chlamydial cervicitis.
The theory that douching disrupts the normal
vaginal flora and selects for BV has little, if any,
microbiologic foundation as it involves the
effects of douching. To date, there are only two
studies with douching which possess sequential
quantitative and qualitative microbiologic observ-
ations. Onderdonk and co-workers25 evaluated
the quantitative and qualitative effects of two
douching preparations on the vaginal microbial
flora. The 0.04% acetic acid douche caused
transient reduction in the total bacterial count
which was attributed to a wash-out effect. The
0.3% povidone–iodine preparation confirmed the
earlier work of Monif and co-workers26; it caused
a statistically significant reduction in the total
bacterial counts when compared to physiologic
saline in the same subjects. Monif and co-workers
have demonstrated that povidone–iodine gel
caused a dramatic, but transient elimination of
bacterial isolates from the female genital tract26.
The first bacteria to recover logarithmic growth
were the aerobic natural constituents of the female
genital tract flora.
Science demands that in order to attain
perceived validation, a hypothesis must account
for the exceptions. That douching causes BV
does not account for the ability of 7 to 10 days
of vaginal douching with povidone–iodine to
achieve clinical and less often microbiologic cures
in women diagnosed as having ‘non-specific
vaginitis/Gardnerella vaginalis/BV’ (Federal Drug
Administration (FDA) study files for Betadine
Gel).
A second exception is identified in the Ness and
co-workers’ papers24 which found that women
who douched before or after sex did not have
an increased risk of BV. This group reported a
statistically higher frequency of sexual intercourse,
on average, than other women in the study.
There is no argument as to the fact that women
who douche, more likely than not, have an
abnormal vaginal flora. What is in contention is
what role douching has in the causation of such a
condition and if so, how. What is done in the
name of women’s healthcare must have a valid
foundation in more than epidemiologic studies.
Executions should not be done on the basis of
circumstantial evidence.
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